Latest On Covetrus, Inc (CVET):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-10-14 01:37 EST | News | Westlake, MillerKnoll jump postmarket on index changes | N/A |  |
| 2022-08-12 01:01 EST | News | Covetrus CFO Matthew Foulston to retire | N/A | |
| 2022-08-04 09:42 EST | News | Covetrus GAAP EPS of -$0.03 misses by $0.06, revenue of $1.22B in-line | N/A | |
| 2022-08-03 19:17 EST | News | Covetrus Q2 2022 Earnings Preview | N/A | |
| 2022-06-03 00:01 EST | News | Clayton, Dubilier & Rice/TPG Are Not Offering Fair Value To Covetrus Shareholders | N/A | |
About Covetrus, Inc (CVET):
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication service read more...s, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
General
- Name Covetrus, Inc
- Symbol CVET
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryHealth Information Services
- Full Time Employees 5,275
- Fiscal Year EndDecember
- IPO Date2019-02-05
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Providers & Services
- Gic SubIndustrySpecialized Consumer Services
- Web URLhttp://www.covetrus.com
Valuation
- Forward PE 34.36
- Price/Sales (Trailing 12 Mt.) 0.87
- Price/Book (Most Recent Quarter) 2.82
- Enterprise Value Revenue 1.18
- Enterprise Value EBITDA 24.04
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.91
- Next Year EPS Estimate $1.06
- Next Quarter EPS Estimate $0.18
- Profit Margin 0%
- Operating Margin -1%
- Return on Assets -1%
- Return on Equity -1%
- Revenue 4.34 billion
- Earnings Per Share $0.30
- Revenue Per Share $36.77
- Gross Profit 798 million
- Quarterly Earnings Growth 11.3%
Highlights
- Market Capitalization 4.08 billion
- EBITDA 112 million
- PEG Ratio 1.66
- Analyst Target Price $34.4
- Book Value Per Share $11.30
Share Statistics
- Shares Outstanding 136.22 million
- Shares Float 99.02 million
- % Held by Insiders 107%
- % Held by Institutions 103.75%
- Shares Short 5.32 million
- Shares Short Prior Month 5.82 million
- Short Ratio 7.21
- Short % of Float 4%
- Short % of Shares Outstanding 4%
Technicals
- Beta 2.21
- 52 Week High $40.78
- 52 Week Low $5.56
- 50 Day Moving Average 34.92
- 200 Day Moving Average 29.07
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Covetrus, Inc (CVET) Dividend Calendar:
Covetrus, Inc (CVET) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Covetrus, Inc (CVET) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Covetrus, Inc (CVET) Chart:
Covetrus, Inc (CVET) News:
Below you will find a list of latest news for Covetrus, Inc (CVET) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Covetrus, Inc (CVET) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest CVET Trades:
Covetrus, Inc (CVET) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-10-26 | DEF 14A (Other definitive proxy statements) | |
| 2020-10-23 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-19 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-16 | PRE 14A (Other preliminary proxy statements) | |
| 2020-10-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-30 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-29 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-25 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-11 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-09 | 8-K (Current report) | |
| 2020-09-09 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-03 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-09-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-13 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-11 | 8-K (Current report) | |
| 2020-08-11 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-07-24 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-23 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-21 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-06 | 4 (Statement of changes in beneficial ownership of securities) | |
Covetrus, Inc (CVET) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Covetrus, Inc (CVET). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 107%
Institutional Ownership: 10375%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-10-21 | Benjamin Wolin | President and CEO | Buy | 21,615.00 | 78,888.00 | | ||
| 2020-10-15 | Georgina Wraight | Officer | Buy | 10,000.00 | 8.60 | 86,000.00 | 12,237.00 | |
| 2020-10-15 | Georgina Wraight | Officer | Sell | 10,000.00 | 27.00 | 270,000.00 | 2,237.00 | |
| 2020-09-29 | Georgina Wraight | Officer | Buy | 10,000.00 | 8.60 | 86,000.00 | 12,237.00 | |
| 2020-09-29 | Georgina Wraight | Officer | Sell | 10,000.00 | 25.00 | 250,000.00 | 2,237.00 | |
| 2020-09-28 | Michael Ellis | Officer | Sell | 3,721.00 | 23.65 | 87,993.09 | 3,986.00 | |
| 2020-09-25 | Georgina Wraight | Officer | Buy | 15,000.00 | 8.60 | 129,000.00 | 17,237.00 | |
| 2020-09-25 | Georgina Wraight | Officer | Sell | 15,000.00 | 23.00 | 345,000.00 | 2,237.00 | |
| 2020-09-23 | DUSTIN FINER | Chief Administrative Officer | Buy | 25,940.00 | 25,940.00 | | ||
| 2020-09-04 | Benjamin Wolin | President and CEO | Buy | 9,259.00 | 61,266.00 | | ||
| 2020-07-21 | Timothy Ludlow | Officer | Buy | 72,604.00 | 0.37 | 26,863.48 | 72,604.00 | |
| 2020-07-17 | Timothy Ludlow | Officer | Sell | 1,741.00 | 20.75 | 36,120.53 | 0.00 | |
| 2020-07-17 | Timothy Ludlow | Officer | Sell | 50,576.00 | 20.89 | 1,056,320.22 | 1,741.00 | |
| 2020-07-01 | Edward McNamara | Director | Sell | 979.00 | 43.05 | 42,145.95 | 40,813.00 | |
| 2020-07-01 | Timothy Ludlow | Officer | Sell | 2,165.00 | 43.05 | 93,203.25 | 52,317.00 | |
| 2020-05-21 | Edward McNamara | Director | Sell | 20,000.00 | 15.03 | 300,600.00 | 41,792.00 | |
| 2020-05-02 | Laura J Phillips | Officer | Buy | 4,042.00 | 4,042.00 | | ||
| 2020-04-21 | Benjamin Wolin | President and CEO | Buy | 21,615.00 | 42,920.00 | | ||
| 2020-03-06 | Anthony C. Jr. Providenti | Officer | Buy | 2,530.00 | 11,232.00 | | ||
| 2020-03-04 | Anthony C. Jr. Providenti | Officer | Buy | 3,027.00 | 9,890.00 | |